- Home
- IHRT vs FHTX Comparison
IHRT vs FHTX Comparison
Compare IHRT & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- FHTX
- Stock Information
- Founded
- IHRT 1974
- FHTX 2015
- Country
- IHRT United States
- FHTX United States
- Employees
- IHRT N/A
- FHTX N/A
- Industry
- IHRT Broadcasting
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- IHRT Consumer Discretionary
- FHTX Health Care
- Exchange
- IHRT Nasdaq
- FHTX Nasdaq
- Market Cap
- IHRT 315.3M
- FHTX 278.1M
- IPO Year
- IHRT 2019
- FHTX 2020
- Fundamental
- Price
- IHRT $2.99
- FHTX $4.98
- Analyst Decision
- IHRT Buy
- FHTX Strong Buy
- Analyst Count
- IHRT 3
- FHTX 6
- Target Price
- IHRT $2.92
- FHTX $11.33
- AVG Volume (30 Days)
- IHRT 761.6K
- FHTX 84.8K
- Earning Date
- IHRT 11-06-2025
- FHTX 11-03-2025
- Dividend Yield
- IHRT N/A
- FHTX N/A
- EPS Growth
- IHRT N/A
- FHTX N/A
- EPS
- IHRT N/A
- FHTX N/A
- Revenue
- IHRT $3,867,156,000.00
- FHTX $24,173,000.00
- Revenue This Year
- IHRT $0.32
- FHTX $43.75
- Revenue Next Year
- IHRT $5.61
- FHTX $1.27
- P/E Ratio
- IHRT N/A
- FHTX N/A
- Revenue Growth
- IHRT 3.18
- FHTX N/A
- 52 Week Low
- IHRT $0.95
- FHTX $2.95
- 52 Week High
- IHRT $3.00
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- IHRT 74.46
- FHTX 44.42
- Support Level
- IHRT $2.08
- FHTX $5.14
- Resistance Level
- IHRT $2.31
- FHTX $5.58
- Average True Range (ATR)
- IHRT 0.22
- FHTX 0.34
- MACD
- IHRT 0.06
- FHTX -0.04
- Stochastic Oscillator
- IHRT 73.54
- FHTX 8.42
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.